autotaxin inhibitor (Bristol-Myers Squibb)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameautotaxin inhibitor (Bristol-Myers Squibb)
Drug Alias Nameautotaxin inhibitor (Amira)AM-063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsFibrosisNeuralgiaLiver Cirrhosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmira Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmira Pharmaceuticals IncBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsFibrosisNeuralgiaLiver Cirrhosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A